Plasma levels of platelet-derived growth factor BB and transforming growth factor in patients with failed hip prostheses

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Acta Orthopaedica

• Publication date

  2005-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/00016470510030337PMID 15788309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming growth factor-β

  2007cited by this paper
• Mitogens are increased in the systemic circulation during bone callus healing

  2003cited by this paper
• Plasma levels of coagulation inhibitors, fibrinolytic markers and platelet-derived growth factor-AB in patients with failed hip prosthesis

  2003cited by this paper
• Twenty-five-Year Survivorship of Two Thousand Consecutive Primary Charnley Total Hip Replacements: Factors Affecting Survivorship of Acetabular and Femoral Components

  2002cited by this paper
• Twenty-five-Year Survivorship of Two Thousand Consecutive Primary Charnley Total Hip Replacements

  2002cited by this paper
• Positive cytokine production in failed metal-on-metal total hip replacements

  2002cited by this paper
• Dense innervation in pseudocapsular tissue compared to aneural interface tissue in loose totally replaced hips.

  2002cited by this paper
• Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions

  2001cited by this paper
• Transforming growth factor-beta induces osteoclast ruffling and chemotaxis: potential role in osteoclast recruitment.

  2001cited by this paper
• High‐Turnover Periprosthetic Bone Remodeling and Immature Bone Formation Around Loose Cemented Total Hip Joints

  2001cited by this paper
• Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage.

  1999cited by this paper
• Immunohistochemical evaluation of interface membranes from failed cemented and uncemented acetabular components.

  1999cited by this paper
• Production of platelet-derived growth factor in aseptic loosening of total hip replacement

  1998cited by this paper
• Variation in cytokines induced by particles from different prosthetic materials.

  1998cited by this paper
• Transforming growth factor-beta and platelet derived growth factor regulation of fibrillar fibronectin matrix formation by synovial fibroblasts.

  1998cited by this paper
• Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty.

  1997cited by this paper
• Heterogeneity in cellular and cytokine profiles from multiple samples of tissue surrounding revised hip prostheses.

  1996cited by this paper
• The effect of systemically administered PDGF‐BB on the rodent skeleton

  1996cited by this paper
• Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization.

  1993cited by this paper

• A review on the safety of growth factors commonly used in cultivated meat production.

  2024cites this paper
• Angiogenic Growth Factors for Coronary Artery Disease: Current Status and Prospects

  2018cites this paper
• Enzymes and cytokines disease in total hip arthroplasty: promoters of immune loosening

  2018cites this paper
• Design principles for therapeutic angiogenic materials

  2016cites this paper
• Osteogenetic growth factors around loosened hip replacements

  2014cites this paper
• Systemic and local TGF-Ã1 concentration in patients with aseptic loosening of hip prostheses

  2010influential citation
• The local inflammatory environment and microorganisms in "aseptic" loosening of hip prostheses.

  2008cites this paper
• Circulating Cytokines as Biological Indicators for PE and Ceramics Articulations

  2007cites this paper